- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04246970
Prehabilitation and Posttransplant Training Program in Liver Transplantation (PreLiveR-T)
Effects of a Prehabilitation Program in Liver Transplant Candidates Followed by a Posttransplant Training Program
PreLiveR-T consists of a prospective randomized clinical trial conducted in an adult population that is a candidate for liver transplantation (LT) at the Hospital La Fe Valencia (Spain). The study is structured in three phases: I) Prehabilitation (2 months before LT); II) Training, divided in two successive periods: Supervised training (months 3-6 after LT) and Unsupervised training (6-12 months after LT); III) Long-term follow-up (2 years after LT).
Primary outcomes are related to post-surgery evolution (morbidity and mortality, hospitalization length, etc.). As a secondary outcomes are collected those related to: functional capacity, muscle strength and quality of life.
Study Overview
Status
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Valencia, Spain, 46026
- Hospital Universitari i Politècnic La Fe
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Indication of elective liver transplant with favorable cardiorespiratory evaluation that does not contraindicate the transplant.
Exclusion Criteria:
- Any orthopedic, motor, functional, neurological, cognitive or linguistic limitation that prevents the realization of the Prehabilitation program
- Inability to perform psychometric tests
- Esophageal varices not treated with ligature or beta-blockers
- Varicose veins with a high risk of digestive hemorrhage
- Hemoglobin <80 g/l
- Contraindication to weight loading
- Impossibility to comply with the Prehabilitation program (hospital admission, work, geographical location)
- Multi-organ transplantation and liver retransplantation
- Refusal or lacks capacity to give informed consent
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control group
Conventional medical care
|
|
Experimental: Prehabilitation group
Conventional medical care and 8 weeks of a Prehabilitation supervised program
|
Supervised training program of 8-weeks and a frequency of 2 days/week.
It includes interval aerobic exercise (5 cycles of 2 minutes at 70 percentage of Watts or heart rate of cardiopulmonary exercise testing (CEPT) and 3 minutes of active rest at 40 percentage; peripheral muscle training and balance exercises in a circuit of 10 phases, 10 to 15 repetitions, from 1 to 3 sets (the participants will work at moderate intensity, no more than 5-6/10 on the modified Borg scale); Inspiratory Muscle Training (IMT) through a threshold loading device [2 sessions / day, 3 sets of 15 repetitions, at 60-70 percentage of the maximum inspiratory pressure (cmH2O)]; ventilatory reeducation by an incentive inspirator based on the vital capacity evaluated in the initial spirometry.
Both the aerobic modality and the resistance training, will increase the intensity of work (HR, Watts, Kg or cmH2O) between 2-5 percentage every 2 weeks complying with the principle of training overload.
Other Names:
|
Experimental: Prehabilitation and posttransplant training group
Conventional medical care, 8 weeks of a Prehabilitation supervised program and a posttransplant training program.
|
Supervised training program of 8-weeks and a frequency of 2 days/week.
It includes interval aerobic exercise (5 cycles of 2 minutes at 70 percentage of Watts or heart rate of cardiopulmonary exercise testing (CEPT) and 3 minutes of active rest at 40 percentage; peripheral muscle training and balance exercises in a circuit of 10 phases, 10 to 15 repetitions, from 1 to 3 sets (the participants will work at moderate intensity, no more than 5-6/10 on the modified Borg scale); Inspiratory Muscle Training (IMT) through a threshold loading device [2 sessions / day, 3 sets of 15 repetitions, at 60-70 percentage of the maximum inspiratory pressure (cmH2O)]; ventilatory reeducation by an incentive inspirator based on the vital capacity evaluated in the initial spirometry.
Both the aerobic modality and the resistance training, will increase the intensity of work (HR, Watts, Kg or cmH2O) between 2-5 percentage every 2 weeks complying with the principle of training overload.
Other Names:
Prehabilitation will be followed by a posttransplant training program.
In this, the patient will perform supervised exercise (IIa interval aerobic exercise and resistance training) 2 days / week, and a physical exercise program at home until completing a total of 5 sessions / week in the aerobic modality.
In the unsupervised phase (IIb), the patient will continue with the learned physical exercise program, but without supervision, 5 sessions / week (including a minimum of 2 non-consecutive sessions to perform resistance training).
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Morbidity
Time Frame: The groups will be assessed from the hospitalization up to 24-months.
|
Registry of post-surgical complications according to the Clavien-Dindo classification.
Reference: Ann Surg 2004; 240(2):205-13.
|
The groups will be assessed from the hospitalization up to 24-months.
|
Mortality
Time Frame: The groups will be assessed from the hospitalization until the date of death, assessed up to 24-months.
|
Registry of mortality
|
The groups will be assessed from the hospitalization until the date of death, assessed up to 24-months.
|
Number of hospitalization days
Time Frame: The groups will be assessed during hospitalization, approximately 7 days.
|
Registry of number of days of hospitalization in intensive care unit and ward.
|
The groups will be assessed during hospitalization, approximately 7 days.
|
Number of days with supplementary oxygen therapy and/or mechanical ventilation
Time Frame: The groups will be assessed during hospitalization, approximately 7 days.
|
Registry of number of days
|
The groups will be assessed during hospitalization, approximately 7 days.
|
Progression in the activities of daily life (ADL)
Time Frame: The groups will be assessed during hospitalization, approximately 7 days.
|
Days of acquisition, sitting, walking and stairs
|
The groups will be assessed during hospitalization, approximately 7 days.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in functional capacity: measurement of oxygen uptake
Time Frame: The groups will be assessed at four times: at baseline; at week 8; 3-months after LT; and 6-months after LT.
|
Cardiopulmonary exercise test following an incremental protocol on ramp with a bicycle ergometer.
|
The groups will be assessed at four times: at baseline; at week 8; 3-months after LT; and 6-months after LT.
|
Change in functional capacity: 6-minutes walking test (6MWT)
Time Frame: The groups will be assessed at four times: at baseline; at week 8; 3-months after LT; and 6-months after LT.
|
6MWT is a submaximal exercise test that entails measurement of distance walked over a span of 6 minutes.
The 6 MWT provides information regarding functional capacity, response to therapy and prognosis.
American Thoracic Society (ATS) Statement Guidelines for the Six-Minute Walk Test.
Am J Resp Crit Care Med 2002;166(1):111-117
|
The groups will be assessed at four times: at baseline; at week 8; 3-months after LT; and 6-months after LT.
|
Change in peripheral muscle strength: handgrip strength, quadriceps femoris strength and biceps brachii strength
Time Frame: The groups will be assessed at six times: at baseline; at week 8; 1-month, 3-months, 6-months and 24-months after LT.
|
Isometric peripheral muscle strength will be measured using a digital hand dynamometer and the unit of measure is kilograms. References: Roberts HC, Denison HJ, Martin HJ, Patel HP, Syddall CC, Sayer AA. A review of the measurement of grip strength in clinical and epidemiological studies: towards a standardised approach. Age and Ageing 2011;40(4):423-9. Andrews AW, Thomas MW, Bohannon RW. Normative values for isometric muscle force measurements obtained with hand-held dynamometers. Phys Ther. 1996; 76(3):248-59 |
The groups will be assessed at six times: at baseline; at week 8; 1-month, 3-months, 6-months and 24-months after LT.
|
Change in respiratory strength: maximum inspiratory pressure (MIP) and maximum expiratory pressure (MEP)
Time Frame: The groups will be assessed at baseline and at week 8.
|
Maximum respiratory pressures will be measured using a Respiratory Pressure Meter MicroRPM® and the unit of measure is cmH2O.
MIP and MEP are probably the most frequently reported non-invasive estimates of respiratory muscle strength.
Ever since Black and Hyatt (1969) reported this technique it has been widely used in patients, healthy control subjects across all ages, and athletes.
Pressure is recorded at the mouth during a quasi-static short (few seconds) maximal breathing.
Reference: Am J Respir Crit Care Med.
2002;166:531-535
|
The groups will be assessed at baseline and at week 8.
|
Change in performance on the Short Physical Performance Battery (SPPB)
Time Frame: The groups will be assessed at six times: at baseline; at week 8; 1-month, 3-months, 6-months and 24-months after LT.
|
The SPPB is a simple test to measure lower extremity function using tasks that mimic daily activities.
The SPPB examines three areas of lower extremity function; static balance, gait speed, and getting in and out of a chair.
Static balance is measured in units of time (seconds) and patients are timed holding 3 different stances.
Gait speed is measured in time (seconds) to walk 4 meters.
Chair sits are measured as the time (seconds) it takes to get up and out of a chair 5 times without using one's arms to assist the exercise.
Collectively, the three tests are used to generate a total score (0-12) that reflects a patient's frailty (score of 0) or lack of frailty (score of 12).
Guralnik JM, Simonsick EM, Ferrucci L, Glynn RJ, Berkman LF, Blazer DG, Scherr PA, Wallace RB.
A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission.
J Gerontol.
1994;49:M85-M94.
|
The groups will be assessed at six times: at baseline; at week 8; 1-month, 3-months, 6-months and 24-months after LT.
|
Change in muscle mass
Time Frame: The groups will be assessed at six times: at baseline; at week 8; 1-month, 3-months, 6-months and 24-months after LT.
|
Bioelectrical impedance analysis will be completed using the Bodystat 1500 MDD, which is a multi-frequency body composition analyzer.
Body fat percentage (%) will be compared to lean body mass percentage and total body water percentage to assess sarcopenia and nutritional status.
|
The groups will be assessed at six times: at baseline; at week 8; 1-month, 3-months, 6-months and 24-months after LT.
|
Change in Quality of life
Time Frame: The groups will be assessed at six times: at baseline; at week 8; 1-month, 3-months, 6-months and 24-months after LT.
|
Short-Form Liver Disease Quality of Life (SF-LDQOL) is formed by 9 dimensions: symptoms of the disease, effects of the disease on the activities of daily life, memory/concentration, anxiety, sleep, loneliness, hopelessness, stigma for the disease and sexual functioning.
The minimum and maximum values of the scale are 0-100, so that the higher the score, the better health related quality of life (HRQL).
|
The groups will be assessed at six times: at baseline; at week 8; 1-month, 3-months, 6-months and 24-months after LT.
|
Collaborators and Investigators
Collaborators
Publications and helpful links
General Publications
- Barberan-Garcia A, Ubre M, Roca J, Lacy AM, Burgos F, Risco R, Momblan D, Balust J, Blanco I, Martinez-Palli G. Personalised Prehabilitation in High-risk Patients Undergoing Elective Major Abdominal Surgery: A Randomized Blinded Controlled Trial. Ann Surg. 2018 Jan;267(1):50-56. doi: 10.1097/SLA.0000000000002293.
- Brustia R, Savier E, Scatton O. Physical exercise in cirrhotic patients: Towards prehabilitation on waiting list for liver transplantation. A systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2018 Jun;42(3):205-215. doi: 10.1016/j.clinre.2017.09.005. Epub 2017 Nov 20.
- Debette-Gratien M, Tabouret T, Antonini MT, Dalmay F, Carrier P, Legros R, Jacques J, Vincent F, Sautereau D, Samuel D, Loustaud-Ratti V. Personalized adapted physical activity before liver transplantation: acceptability and results. Transplantation. 2015 Jan;99(1):145-50. doi: 10.1097/TP.0000000000000245.
- Williams FR, Vallance A, Faulkner T, Towey J, Durman S, Kyte D, Elsharkawy AM, Perera T, Holt A, Ferguson J, Lord JM, Armstrong MJ. Home-Based Exercise in Patients Awaiting Liver Transplantation: A Feasibility Study. Liver Transpl. 2019 Jul;25(7):995-1006. doi: 10.1002/lt.25442. Epub 2019 Jun 6.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019/0227
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Liver Transplant; Complications
-
PilloxaTerminatedLiver Transplant; Complications | Kidney Transplant; ComplicationsSweden
-
Zhejiang UniversityNot yet recruitingLiver Transplant; Complications
-
Institute of Liver and Biliary Sciences, IndiaRecruitingLiver Transplant; ComplicationsIndia
-
Universidade Federal do Rio de JaneiroUniversity of California, San FranciscoUnknownLiver Transplant; ComplicationsBrazil
-
Société Française d'Anesthésie et de RéanimationLaboratoire français de Fractionnement et de BiotechnologiesNot yet recruitingLiver Transplant; ComplicationsFrance
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingLiver Transplant; ComplicationsItaly
-
Hospital Universitari Vall d'Hebron Research InstituteCompletedLiver Transplant; ComplicationsSpain
-
Seoul St. Mary's HospitalEnrolling by invitationLiver Transplant; ComplicationsKorea, Republic of
-
Boston Scientific CorporationCompletedLiver Transplant; ComplicationsSpain, United States, Netherlands, Brazil
-
Seoul National University HospitalCompletedLiver Transplant; ComplicationsKorea, Republic of
Clinical Trials on Prehabilitation
-
Stanford UniversityRecruitingSurgery | Thoracic Diseases | Gastrointestinal Disease | Preoperative Care | Gynecologic Disease | Immune System and Related Disorders | Urological DiseaseUnited States
-
Istituto Ortopedico GaleazziMinistry of Health, ItalyRecruiting
-
Mount Sinai Hospital, CanadaUniversity Health Network, TorontoUnknownPhysical Activity | Surgery | Gastrointestinal Cancer | PrehabilitationCanada
-
Belfast Health and Social Care TrustQueen's University, BelfastRecruitingLiver TransplantUnited Kingdom
-
Nova Scotia Health AuthorityDalhousie UniversityNot yet recruiting
-
University Health Network, TorontoRecruiting
-
University Hospital, ToulouseRecruitingAbdominal Aortic AneurysmFrance
-
McGill University Health Centre/Research Institute...Recruiting
-
Guy's and St Thomas' NHS Foundation TrustCompletedVascular SurgeryUnited Kingdom
-
Imperial College Healthcare NHS TrustCambridge University Hospitals NHS Foundation Trust; Mid and South Essex NHS...CompletedAortic Aneurysm, AbdominalUnited Kingdom